文献速递前列腺癌

极低危前列腺癌即刻治疗与主动监测的差异及医院相关因素

Immediate treatment vs. active-surveillance in very-low-risk prostate cancer: the role of patient-, tumour-, and hospital-related factors.
PubMed 文献 · Prostate Cancer Prostatic Dis · 2018-11-14

基于荷兰癌症登记2015–2016年2396例极低危前列腺癌患者,85.4%接受主动监测(AS)。医院间粗AS比例33.3%–100%,病例组合调整后71%–97%。肿瘤分期cT2a、阳性穿刺针数2针、诊断性MRI、多学科团队讨论、与患者讨论治疗方案及医院类型与即刻治疗相关。

要点

  • 极低危前列腺癌多数接受AS,但医院间差异显著。
  • cT2a、2针阳性、MRI、MDT讨论及讨论治疗方案与即刻治疗相关。
  • 非大学转诊医院较社区医院更少即刻治疗。

核心结论

  • 荷兰极低危前列腺癌多数以AS管理,但医院间存在差异,部分差异由患者和肿瘤特征解释,医院相关因素也起作用,提示临床实践可改进。

研究设计与样本

  • 基于人群的荷兰癌症登记研究,纳入2015和2016年诊断的极低危前列腺癌患者共2396例。
  • 采用多水平logistic回归分析,评估按诊断医院分的粗概率和病例组合调整后即刻治疗vs AS概率,并评价患者、肿瘤和医院相关因素效应。

主要发现

  • 2396例极低危前列腺癌患者中2047例(85.4%)接受AS管理。
  • 医院间粗AS比例从33.3%到100%不等,病例组合调整后概率从71%到97%不等。
  • 肿瘤分期cT2a vs cT1c(OR 2.0,95%CI 1.1-3.6)与即刻治疗相关。
  • 阳性穿刺针数2 vs 1(OR 2.8,95%CI 1.6-4.7)、诊断性MRI(OR 2.8,95%CI 1.5-5.2)与即刻治疗相关。
  • 多学科团队讨论(OR 2.2,95%CI 1.1-4.5)、与患者讨论治疗方案(OR 3.3,95%CI 1.5-7.4)及医院类型(非大学转诊医院 vs 社区医院:OR 0.5,95%CI 0.2-0.9)与即刻治疗相关。

关键数值与推荐

  • 极低危定义:cT1c-cT2a、PSA < 10 ng/ml、Gleason评分 <7且阳性穿刺针数 <3。

临床怎么用

  • 极低危前列腺癌应以AS为主要管理策略,但需关注医院间实践差异。
  • 临床决策中应综合考虑肿瘤分期、穿刺针数、MRI使用及多学科讨论等因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: To provide insight in the treatment variation of very-low-risk prostate cancer patients and to assess the role of hospital-related factors. METHODS: All patients diagnosed with very-low-risk prostate cancer (cT1c-cT2a, PSA < 10 ng/ml, Gleason score <7 and <3 positive cores) in 2015 and 2016 were identified through the population-based Netherlands Cancer Registry. Multilevel logistic regression analyses were performed to examine the crude and case-mix adjusted probability of immediate treatment vs. active-surveillance (AS) according to hospital of diagnosis and to evaluate the effect of patient-, tumour-, and hospital-related factors. RESULTS: In all, 2047 (85.4%) of the 2396 patients with very-low-risk prostate cancer were managed with AS. The crude proportion of patients with AS varied from 33.3 to 100% between hospitals. Case-mix adjusted probability varied from 71 to 97%. Tumour stage cT2a vs. cT1c (OR 2.0, 95%CI 1.1-3.6), two vs. one positive core (OR 2.8, 95%CI 1.6-4.7), diagnostic MRI (OR 2.8, 95%CI 1.5-5.2), discussion of a patient in a multi-disciplinary team (OR 2.2, 95%CI 1.1-4.5), discussion of treatment options with the patient (OR 3.3, 95%CI 1.5-7.4) and type of hospital (non-university referral hospital vs. community hospital: OR 0.5, 95%CI 0.2-0.9) were associated with immediate treatment. CONCLUSION: The majority of Dutch very-low-risk prostate cancer patients is managed with AS but variation between hospitals exists. Part of the variation is explained by patient- and tumour characteristics but also hospital-related factors play a role. This implies that clinical practice could be improved.

来源:Prostate Cancer Prostatic Dis,查看原文。版权归原作者所有。

引用

  1. Jansen H, van Oort IM, van Andel G, et al. Immediate treatment vs. active-surveillance in very-low-risk prostate cancer: the role of patient-, tumour-, and hospital-related factors. Prostate Cancer Prostatic Dis. 2018. PMID: 30429595. doi:10.1038/s41391-018-0109-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。